Bausch + Lomb to name Brent Saunders as CEO – WSJ

Bausch + Lomb to name Brent Saunders as CEO - WSJ

(Reuters) -Eye-care company Bausch + Lomb Corp is expected to name Brent Saunders, the former chief executive of Allergan, as its CEO and chairman of board, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

The leadership change could be announced as soon as Wednesday, according to the report.

Bausch + Lomb is in the process of being spun out from Bausch Health Companies, which was formerly known as Valeant.

Brent Saunders served as the CEO of Allergan until it was bought out by AbbVie Inc for $63 billion in 2020.

Bausch + Lomb did not immediately respond to a Reuters request for comment.

(Reporting by Maria Ponnezhath, Manas Mishra and Raghav Mahobe in Bengaluru; Editing by Sherry Jacob-Phillips)

Gold Price Forecast XAU/USD – Stubborn US Inflation Data Adding to Rate-Hike WorriesNatural Gas Shows Bullish Divergence with Momentum OscillatorNASDAQ, S&P 500, Dow Jones Analysis – Stocks Rebound From Session LowsXRP Bears to Target Sub-$0.3650 on SEC Activity and Fed FearPalantir Gains 15% After Reporting Its First GAAP ProfitEUR/USD Needs a Hawkish Lagarde and Weak US Consumption for $1.08LoadingLoadingLoading